Clinical Trials Sponsored by Dynamics Research Corporation

Total 721 results

Meshalkin Research Institute of Pathology of Circulation
Spectrum Dynamics

Unknown

Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology

Atrial Fibrillation

Russian Federation
MedVadis Research Corporation

Completed

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

Chronic Pain

United States
Pope Research Corporation

Unknown

Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s)

Rheumatoid Arthritis

Canada
Epitopoietic Research Corporation

Not yet recruiting

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

Glioma, Malignant

Thailand
MedVadis Research Corporation

Completed

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

Chronic Daily Headache

United States
Bioelectric Research Corporation

Unknown

Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery

Wounds and Injuries | Edema | Osteoarthritis of Knee

United States
Beth Israel Deaconess Medical Center
Harvard Risk Management Foundation; Dynamics Research Corporation; Armed Forces... and other collaborators

Completed

The Labor and Delivery Teamwork Intervention Trial

Adverse Maternal and Neonatal Outcomes

United States
TearLab Corporation
Alcon Research

Completed

TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease (CVS)

Keratoconjunctivitis Sicca

United States, Spain, France, Germany, United Kingdom
Silver Lake Research Corporation

Unknown

Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings

Diagnoses Disease

United States
Incyte Corporation
Innovaderm Research

Completed

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Atopic Dermatitis

United States
American Research Corporation
AbbVie

Completed

A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study (HEARTLAND)

Chronic Hepatitis C
Pope Research Corporation
Amgen

Withdrawn

Psoriatic Arthritis Treat to Target vs. Usual Care (PRC-05-2011)

Psoriatic Arthritis (PsA)

Canada
Electrophysiology Research Foundation
Axio Research Corporation

Terminated

EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation (ENTICED-AF)

Atrial Fibrillation

United States
Ottawa Heart Institute Research Corporation

Not yet recruiting

Exercise Testing Protocols for Females and Males With CAD (PACED)

Coronary Artery Disease
Ottawa Heart Institute Research Corporation

Not yet recruiting

Dapagliflozin in STEMI Randomized Clinical Trial (DAPA STEMI)

Myocardial Infarction | ST Elevation Myocardial Infarction

Canada
Ottawa Heart Institute Research Corporation

Not yet recruiting

Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users (VC-OMSC)

Tobacco Smoking | Vaping
Ottawa Heart Institute Research Corporation

Recruiting

Exercise Training in Women With Cardiac Devices (CIED-EX)

Cardiovascular Diseases

Canada
Ottawa Heart Institute Research Corporation

Recruiting

An Interactive Smartphone Application to Motivate Smokers to Quit (StepOne)

Smoking Cessation | Smoking Behaviors

Canada
Ottawa Heart Institute Research Corporation

Recruiting

CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock (DOREMI-2)

Shock, Cardiogenic

United States, Canada
Ottawa Heart Institute Research Corporation

Recruiting

QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT) (QOL-CAFRCT)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation (ACUTE-AF)

Atrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry (COVID-VIHPR)

Myocarditis | Pericarditis

Canada
Ottawa Heart Institute Research Corporation

Completed

Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias

Arrythmia

Canada
Matrivax Research and Development Corporation

Active, not recruiting

A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine

Pneumococcal Vaccine

United States
Ottawa Heart Institute Research Corporation

Active, not recruiting

The COVID-RASi Trial (COVID-19)

Cardiovascular Diseases | COVID-19

Brazil, Canada, Mexico
Ottawa Heart Institute Research Corporation

Suspended

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND (RAPID EXTEND)

Myocardial Infarction | Coronary Artery Disease

Canada
Concert Pharmaceuticals
Cognitive Research Corporation

Completed

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia

Schizophrenia

United States
Ottawa Heart Institute Research Corporation

Enrolling by invitation

Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment (TRIGISTRY)

Tricuspid Regurgitation

United States, Spain, Israel, Canada, France, Germany, Netherlands, Switzerland, Austria, Italy
Ottawa Heart Institute Research Corporation

Completed

The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses (WALK)

Cardiovascular Diseases | Cardiovascular Risk Factor

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Feasibility of Transepicardial Atrial Injection

Cardiac Surgery

Canada
Ottawa Heart Institute Research Corporation

Completed

Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study

Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (CAPITAL PCI AF)

Atrial Fibrillation | Acute Coronary Syndrome

Canada
Ottawa Heart Institute Research Corporation

Completed

Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure

Heart Failure

Canada
Ottawa Heart Institute Research Corporation

Completed

Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation (PREHAB HTx Study) (PREHAB)

Heart Failure

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

Coronary Artery Disease | Diabetes Mellitus
Tuscaloosa Research & Education Advancement Corporation

Terminated

Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder

PTSD

United States
Ottawa Heart Institute Research Corporation

Terminated

Optimization of SPECT Imaging (OSCARS)

Coronary Artery Disease

Canada
Celgene Corporation
Prologue Research International

Completed

Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Ovarian Cancer

United States
Ottawa Heart Institute Research Corporation

Terminated

Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention (AVATAR)

Ventricular Tachycardia | Ventricular Arrhythmia

Canada
Ottawa Heart Institute Research Corporation

Completed

Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients

Stroke

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Cardiac Sarcoidosis Response To Steroids Trial (CASTOR)

Sarcoidosis | Cardiac Sarcoidosis

Canada
Ottawa Heart Institute Research Corporation

Completed

Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty

Platelet Reactivity

Canada
Ottawa Heart Institute Research Corporation

Not yet recruiting

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm (SEDATE)

Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Arrhythmias | Recurrent Ventricular Tachycardia
Ottawa Heart Institute Research Corporation

Recruiting

Florbetaben for Imaging of Vascular Amyloid (FERMATA)

Stroke | Transient Ischemic Attack | Acute Coronary Syndrome | Atherosclerosis of Artery

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study (HER-CROWN)

Cardiovascular Diseases

Canada
Ottawa Heart Institute Research Corporation

Not yet recruiting

Canagliflozin Targeting Vascular Inflammation (CANTORSING)

Coronary Artery Disease | Diabetes Type 2

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock (MINOS)

Mitral Regurgitation | Cardiogenic Shock

United States, Canada
Ottawa Heart Institute Research Corporation

Recruiting

Effect of Colchicine on the Progression of Aortic Valve Stenosis - A Pilot Study (COPAS-Pilot)

Inflammation | Aortic Stenosis

Canada
Ottawa Heart Institute Research Corporation

Recruiting

An Evaluation of the Talk Test for Exercise Prescription for Home-Based Cardiac Rehabilitation (Talk-Test)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial (CARA-VT RCT)

Ventricular Tachycardia

Canada

Clinical Trials Sponsored by Dynamics Research Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations